Sign in

CIK 0001789972 · Non-accelerated filer<br>Smaller reporting company

Cullinan Therapeutics, Inc.

Sign in to watch
Ticker
CGEM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
813879991
Phone
617-410-4650
Business address
ONE MAIN STREET, SUITE 1350, CAMBRIDGE, MA, 02142
Former names
Cullinan Oncology, Inc., Cullinan Management, Inc., Cullinan Oncology, LLC
  1. 4 Open-market sale See Remarks sold 28,118 shares at $29.00 ($815,422)
  2. 4 Open-market sale See Remarks sold 4,000 shares at an average $27.66 ($110,648)
  3. 4 Open-market sale 10% owner sold 2,510 shares at $29.05 ($72,916)
  4. 4 Open-market sale Director sold 2,857 shares at $29.05 ($82,996)
  5. 4 Open-market sale See Remarks sold 28,118 shares at an average $26.77 ($752,850)
  6. 8-K Event Results of operations
  7. 10-Q Report Quarterly Report
  8. 8-K Event Shareholder vote results
  9. 8-K Event Regulation FD disclosure · Other events
  10. 8-K Event Executive or director change
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. DEFA14A Proxy Proxy Materials
  14. DEF 14A Proxy Proxy Statement
  15. 10-K Report Annual Report
  16. 8-K Event Results of operations
  17. 8-K Event Bylaws or fiscal year change
  18. 8-K Event Regulation FD disclosure
  19. SC 13D Stake Beneficial Ownership Report
  20. SC 13G Stake Amended Statement of Ownership

Page 21 of 24 · 471 filings